| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.6 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.082 | 0.6 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.086 | 0.6 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |